Prometheus Laboratories Inc

Type: Company
Name: Prometheus Laboratories Inc
Nationality: United States
Web Address: http://www.prometheuslabs.com/
First reported 49 mins ago - Updated 49 mins ago - 1 reports

What to do About All These Invalid Patents?

By Dennis Crouch The recorder-of-deeds here in Boone County Missouri is pretty good at her job. Although there is an occasional error in the records, those errors are quickly remedied once found.  The property records are regularly relied upon and ... [Published Patent Law Blog (Patently-O) - 49 mins ago]
First reported Aug 26 2014 - Updated Aug 26 2014 - 1 reports

Tocagen Fills Key Postions in Clinical Development

San Diego-based Tocagen Inc. announced Wayne Saville has been named vice president of clinical development and Mary Rose Keller has been named vice president of clinical operations."We are expanding our clinical team with individuals who have deep experience ... [Published San Diego Business Journal - Aug 26 2014]
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Examination of Myriad-Mayo Guidance Comments -- AUTM, COGR, AAU, and APLU

By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ... [Published Patent Docs - Aug 22 2014]
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Catalent Appoints Two Executives to Board of Directors

Catalent, Inc. has announced that it made two appointments to its board of directors.Jack Stahl was president and chief executive officer of Revlon, Inc. between 2002 and 2006. Previously, he acted as president and chief operating officer of The Coca-Cola ... [Published PharmTech.com - Aug 18 2014]
First reported Aug 12 2014 - Updated Aug 13 2014 - 2 reports

Stopped at the Threshold: A New Study Reports on PTO Patent Examinations in the wake of Mayo and Myriad

Biotech patent applicants are finding themselves in uncharted waters. After the Supreme Court’s decisions in Mayo Collaborative Svs. v. Prometheus Labs and Ass’n for Molecular Pathology v. Myriad Genetics, companies have been trying to understand ... [Published Patently BIOtech - Aug 12 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

Examination of Myriad-Mayo Guidance Comments -- International Bioindustry Associations

By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ... [Published Patent Docs - Aug 12 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

Examination of Myriad-Mayo Guidance Comments -- ACLU

By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ... [Published Patent Docs - Aug 06 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

Prometheus Labs., Inc. v. Roxane Labs., Inc. (D.N.J.)

Case Name: Prometheus Labs, Inc. v. Roxane Labs, Inc. , Case Nos. 11-230 (FSH), 11-1241 (FSH), Unpublished (D.N.J. May 21, 2014) (Hochberg, J.)Drug Product and Patent(s)-in-Suit: Lotronex® (alosetron hydrochloride); U.S. Pat. No. 6,284,770 (“the ’770 ... [Published JD Supra - Aug 05 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 2 reports

What to know after the latest patent ruling by the U.S. Supreme Court

The Alice ruling clarifies patent-eligible software processes Computerworld - In June, the . In light of that decision, companies and inventors that have business methods patents, software patents or financial methods-based patents should review their ... [Published Computerworld - Jul 28 2014]
First reported Jul 21 2014 - Updated Jul 22 2014 - 3 reports

Patent-Eligible Subject Matter in the United States

1. IntroductionThe United States Patent statute provides that utility patents may be granted for the invention of any new and useful process, machine, manufacture or composition of matter or any new useful improvement thereof. 1This broad statutory definition ... [Published JD Supra - Jul 22 2014]
First reported Jun 24 2014 - Updated Jun 24 2014 - 2 reports

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court issued its decision in Association for Molecular Pathology v. Myriad Genetics, Inc., which concerned the patent eligibility of the BRCA1 and BRCA2 genes. ... [Published Patently BIOtech - Jun 24 2014]
First reported Jun 19 2014 - Updated Jun 20 2014 - 2 reports

Supreme Court Issues Decision in Alice Corp. v. CLS Bank

Alice Corp. v. CLS Bank International (2014) By Kevin E. Noonan -- This morning, in Alice Corp. v. CLS Bank, the Supreme affirmed the Federal Circuit's per curiam opinion in CLS Bank v. Alice Corp. in a unanimous opinion by Justice Thomas with a concurring ... [Published Patent Docs - Jun 19 2014]

Quotes

...in drug development, regulatory approval, launch and commercialization activities," said Jamey Skillings, chief medical officer of Tocagen. "Wayne and Mary Rose bring decades of valuable expertise in clinical development and medical affairs at a pivotal time for Tocagen."
...  Infringement of U S Patent Nos. 6,673,838 ("Succinate Salt of O-Desmethyl-Venlafaxine," issued January 6, 2004) and 8,269,040 ( "Derivatives of Venlafaxine and Methods of Preparing and Using the Same" issued September 18, 2012) following a Paragraph IV certification as part of Intellipharmaceutics' filing of an ANDA to manufacture a generic version...
...decision in Diamond v Diehr in a way that may be useful in determining what is patent-eligible subject matter and how it should be claimed: "In other words, the claims in Diehr were patent eligible because they improved an existing technological process , not because they were implemented on a computer." [10] And, in a footnote, the Court declared that its Mayo analysis is consistent with the patent law principle that the claims should be considered as...
..."  According to the academic organizations, "[t]he examples provided in the Guidance [relating to diagnostic methods] are unclear, ambiguous, and raise more questions than they answer."

More Content

All (55) | News (25) | Reports (0) | Blogs (30) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
What to do About All These Invalid Patents? [Published Patent Law Blog (Patently-O) - 49 mins ago]
Tocagen Fills Key Postions in Clinical Development [Published San Diego Business Journal - Aug 26 2014]
Court Report - August 2014 #4 [Published JD Supra - Aug 25 2014]
Will the USPTO respond to public feedback of it... [Published Lexology - Aug 25 2014]
Supreme Court Issues Decision in Alice Corp. v.... [Published JD Supra - Aug 25 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published JD Supra - Aug 22 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 22 2014]
Catalent Taps Jack Stahl and Rolf Classon to Bo... [Published PredictWallStreet - Aug 20 2014]
Catalent Appoints Two Executives to Board of Di... [Published PharmTech.com - Aug 18 2014]
CATALENT : Confirms the Appointment of Two Seni... [Published 4 Traders - Aug 15 2014]
Stopped at the Threshold: A New Study Reports o... [Published Patently BIOtech - Aug 12 2014]
Stopped at the Threshold: A New Study Reports o... [Published I Am Biotech - Aug 12 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published JD Supra - Aug 12 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 12 2014]
Court Report -- Part II: August 2014 [Published JD Supra - Aug 07 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published JD Supra - Aug 06 2014]
Nodality appoints NLV Partners’ LaPorte as chie... [Published PE Hub Blog - Aug 06 2014]
IBS, Chronic Idiopathic Constipation: New Guide... [Published Diabetes Care - Aug 06 2014]
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 06 2014]
Prometheus Labs., Inc. v. Roxane Labs., Inc. (D... [Published JD Supra - Aug 05 2014]
Supreme Court on evaluation of claims to comput... [Published Lexology - Aug 01 2014]
Federal Circuit Review - Nautilus, Limelight, a... [Published JD Supra - Jul 31 2014]
Supreme Court Continues to Build Out Its Framew... [Published Bureau of National Affairs - Jul 30 2014]
What to know after the latest patent ruling by ... [Published Computerworld - Jul 28 2014]
USPTO Alice Corp. guidelines provide concrete g... [Published Lexology - Jul 28 2014]
What to know after the latest patent ruling by ... [Published Computerworld Australia - Jul 28 2014]
Stewart Title Guaranty Co. v. Segin Software, L... [Published JD Supra - Jul 24 2014]
Patent-Eligible Subject Matter in the United St... [Published JD Supra - Jul 22 2014]
Study: U.S. SC rulings pose challenge to some i... [Published The Southeast Texas Record - Jul 22 2014]
The USPTO’s Response to Alice Corp. v. CLS Bank [Published JD Supra - Jul 22 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
What to do About All These Invalid Patents? [Published Patent Law Blog (Patently-O) - 49 mins ago]
By Dennis Crouch The recorder-of-deeds here in Boone County Missouri is pretty good at her job. Although there is an occasional error in the records, those errors are quickly remedied once found.  The property records are regularly relied upon and ...
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 22 2014]
By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ...
Stopped at the Threshold: A New Study Reports o... [Published Patently BIOtech - Aug 12 2014]
Biotech patent applicants are finding themselves in uncharted waters. After the Supreme Court’s decisions in Mayo Collaborative Svs. v. Prometheus Labs and Ass’n for Molecular Pathology v. Myriad Genetics, companies have been trying to understand ...
Stopped at the Threshold: A New Study Reports o... [Published I Am Biotech - Aug 12 2014]
Biotech patent applicants are finding themselves in uncharted waters. After the Supreme Court’s decisions in Mayo Collaborative Svs. v. Prometheus Labs and Ass’n for Molecular Pathology v. Myriad Genetics, companies have been trying to understand ...
Examination of Myriad-Mayo Guidance Comments --... [Published Patent Docs - Aug 12 2014]
By Donald Zuhn -- On March 4, the U.S. Patent and Trademark Office issued a guidance memorandum, entitled "Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products" (or "Myriad-Mayo ...
1 2 3 4 5 6
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.